Understanding the interplay between the neurotransmitters dopamine and glutamate in the striatum has become the highlight of several theories of neuropsychiatric illnesses, such as schizophrenia. Using in vivo brain imaging in humans, alterations in dopamine and glutamate concentrations have been observed in several neuropsychiatric disorders. However, it is unclear a priori how alterations in striatal dopamine should modulate glutamate concentrations in the basal ganglia. In this selective mini-review, we examine the consequence of reducing striatal dopamine functioning on glutamate concentrations in the striatum and cortex; regions of interest heavily examined in the human brain imaging studies. We examine the predictions of the classical model of the basal ganglia, and contrast it with findings in humans and animals. The review concludes that chronic dopamine depletion (N 4 months) produces decreases in striatal glutamate levels which are consistent with the classical model of the basal ganglia. However, acute alterations in striatal dopamine functioning, specifically at the D 2 receptors, may produce opposite affects. This has important implications for models of the basal ganglia and theorizing about neurochemical alterations in neuropsychiatric diseases. Moreover, these findings may help guide a priori hypotheses for 1 H-MRS studies measuring glutamate changes given alterations in dopaminergic functioning in humans.
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Introduction
Dopamine and glutamate interact with each other in the basal ganglia and prefrontal cortex, intimately regulating each other's function and release (David et al., 2005; Del Arco and Mora, 2008; Jones, 2012) . Abnormalities in these dopaminergic and glutamatergic systems have been observed in numerous neuropsychiatric disorders, including Parkinson's disease (Griffith et al., 2008; Loane and Politis, 2011; Pavese et al., 2011 ), depression (Musazzi et al., 2012 Treadway and Zald, 2011), drug addiction (Martinez et al., 2009; Yang et al., 2009; Yucel et al., 2007) , and schizophrenia (de la Fuente-Sandoval et al., 2013a,b; de la Fuente-Sandoval et al., 2011; Kegeles et al., 2010 ). The classical model of the basal ganglia developed in the 1980s (Obeso and Lanciego, 2011) predicts that loss of striatal dopamine will decrease extracellular levels of glutamate in the striatum and cortex (Albin et al., 1989 (Albin et al., , 1995 Jones, 2012) . Similarly, it predicts that increasing levels of striatal dopamine should increase levels of glutamate in the striatum and cortex. However, the classical model of the basal ganglia is an incomplete one. For instance, it does not take into account the influence of the cholinergic system, and has been criticized for offering a better understanding of pathology rather than normal functioning (Obeso et al., 2008; Obeso et al., 2000) . Undoubtedly, the in vivo environment in which dopamine-glutamate interactions take place in the basal ganglia is far more complex than suggested by the classical model.
Positron emission tomography (PET) and proton magnetic resonance spectroscopy ( 1 H-MRS) are two non-invasive brain-imaging techniques, which allow for quantification of biochemical information about the living human brain. PET employs the use of radiolabelled probes, termed radiotracers or radioisotopes (Baron, 2005; Das, 2015) . These radiotracers are positron emitting isotopes which are chemically incorporated into a biologically active molecule (Das, 2015 
